Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders
- PMID: 35277974
- DOI: 10.1111/head.14282
Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders
Abstract
Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches. Many patients show a rapid therapeutic response to indomethacin, which is limited by intolerability. Etoricoxib and celecoxib, selective inhibitors of cyclo-oxygenase-2 (COX-2), spare gastroduodenal COX-1 activity and are less likely to cause gastrointestinal adverse effects than indomethacin. We report a case series of eight patients, seven who responded to etoricoxib and one patient who responded to celecoxib.
Keywords: celecoxib; cyclo-oxygenase-2 inhibitors; etoricoxib; indomethacin-responsive headache disorders.
© 2022 American Headache Society.
References
REFERENCES
-
- Bahra A. Other primary headaches-thunderclap-, cough-, exertional-, and sexual headache. J Neurol. 2020;267(5):1554-1566. doi:10.1007/s00415-020-09728-0
-
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211. doi:10.1177/0333102417738202
-
- VanderPluym J, Indomethacin-responsive headaches. Curr Neurol Neurosci Rep. 2015;15:516. doi:10.1007/s11910-014-0516-y
-
- Pareja JA, Ruiz J, de Isla C, et al. Idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia. 1996;16(2):93-96. doi:10.1046/j.1468-2982.1996.1602093.x
-
- Lucas S. The pharmacology of indomethacin. Headache. 2016;56(2):436-446. doi:10.1111/head.12769
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
